CHIESI FARMACEUTICI S.P.A.
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- -
- Established
- 1935-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.chiesigroup.com
Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 824
- Registration Number
- NCT00476268
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 828
- Registration Number
- NCT00476099
- Locations
- 🇫🇷
Thomas Similowski, Paris, France
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 219
- Registration Number
- NCT00413387
- Locations
- 🇦🇹
Ambulance For Paediatric and Pulmonology, Wien, Austria
🇵🇱Prywatny Gabinet Lekarski, Lodz, Poland
🇵🇱Nzoz "Medex"Poradnia Alergologiczna, Bielsko-Biala, Poland
EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-11-01
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 180
- Registration Number
- NCT00394368
- Locations
- 🇵🇱
Dolnoslaski Centre of Medical Diagnostic "Dolmed", Wroclaw, Poland
🇺🇦Kharkiv City Clinical Hospital 13 Pulmonological Department, Kharkiv, Ukraine
🇺🇦Institute of Phthisiology and Pulmonology, Academy of Medical Science of Ukraine, Depatment of Diagnostic, Therapy and Clinical Pharmacology of Lung Disease, Kiev, Ukraine
As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-10-02
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 480
- Registration Number
- NCT00382889
- Locations
- 🇵🇱
Clinic of Infection Diseases and Allergology - Central Clinical Hospital of Military Medical Academy, Warszawa, Poland
🇦🇹Pulmologisches Zentrum Der Stadt Wien, Wien, Austria
🇵🇱Specialist Group Medex, Bielsko Biala, Poland
© Copyright 2024. All Rights Reserved by MedPath